Linked Life Data

18547274

Source:http://linkedlifedata.com/resource/pubmed/id/18547274

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-11-26
pubmed:abstractText
To assess the efficacy, duration of effect and safety of one intravitreal injection of bevacizumab in diabetic macular oedema (DMO).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1755-3768
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
800-5
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18547274-Aged, pubmed-meshheading:18547274-Angiogenesis Inhibitors, pubmed-meshheading:18547274-Antibodies, Monoclonal, pubmed-meshheading:18547274-Antibodies, Monoclonal, Humanized, pubmed-meshheading:18547274-Diabetic Retinopathy, pubmed-meshheading:18547274-Female, pubmed-meshheading:18547274-Humans, pubmed-meshheading:18547274-Injections, pubmed-meshheading:18547274-Macular Edema, pubmed-meshheading:18547274-Male, pubmed-meshheading:18547274-Middle Aged, pubmed-meshheading:18547274-Prospective Studies, pubmed-meshheading:18547274-Retina, pubmed-meshheading:18547274-Time Factors, pubmed-meshheading:18547274-Tomography, Optical Coherence, pubmed-meshheading:18547274-Treatment Outcome, pubmed-meshheading:18547274-Vascular Endothelial Growth Factor A, pubmed-meshheading:18547274-Visual Acuity, pubmed-meshheading:18547274-Vitreous Body
pubmed:year
2008
pubmed:articleTitle
Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
pubmed:affiliation
Department of Ophthalmology, Osaka University Medical School, Osaka, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't